Which diagnostic test provides the definitive diagnosis for hepatocellular carcinoma?

Choice A reason: A complete blood count is a general screening tool that provides information about red blood cells, white blood cells, and platelets. While it might reveal secondary effects of liver disease, such as anemia or thrombocytopenia due to splenomegaly, it cannot identify malignant cells or diagnose a specific hepatic tumor. Choice B reason: An abdominal ultrasound is a useful, non-invasive imaging modality for detecting the presence of masses or lesions within the liver parenchyma. However, imaging alone cannot definitively distinguish between benign nodules (like hemangiomas) and malignant hepatocellular carcinoma; it provides anatomical rather than histological confirmation. Choice C reason: Alkaline phosphatase levels are biochemical markers of cholestasis or liver injury. While these levels may be elevated in patients with liver cancer, they are highly non-specific and can be raised in various conditions, including biliary obstruction or bone disease, making them unsuitable for a definitive cancer diagnosis. Choice D reason: A liver biopsy is the gold standard for diagnosis because it involves the histological examination of tissue samples. By analyzing the cellular morphology and architecture under a microscope, pathologists can definitively identify the presence of malignant hepatocytes, confirming a diagnosis of hepatocellular carcinoma and guiding subsequent treatment.